The University of Michigan is investing $17.5m to expand its North Campus Research Complex.

US-based University of Michigan (UoM) has unveiled plans to invest $17.5m to expand research space at its North Campus Research Complex (NCRC), which is already home to 19 UoM spinouts. The project will renovate and open 68k-square feet of space for biomedical research on the site, as well as shared research tools. The site has been used to conduct research into cancer, cardiovascular disease, biointerfaces, healthcare services, transportation, bioinformatics and emergency medicine. The UoM bought the former pharmaceutical research complex in June 2009, and has expanded its headcount to 1,700. On top of the 19 spinout firms supported by UoM’s Venture Accelerator, 10 colleges from within the UoM use the facility, as well as the staff of two private scientific firms. NCRC executive director David Canter, said: “This new project will continue UoM’s commitment to make NCRC a hub for research that translates new discoveries from the laboratory to the marketplace and clinic. We have made good progress in creating a place where UoM scientists and partners from the private and public sectors can work together, and fuel growth that aids the Michigan economy.”

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?